Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: JOHN W. who wrote (3017)	11/26/1997 11:58:00 PM
From: m33806	Respond to of 6136

I am not much of a fan of the U.N. but I do believe their 30 million AIDS number. That says it all. To H with the shorts (they are short term) and who should worry about the WSJ or BS Barrons. That is also short term. Holding the common or longer term calls will reward the faithfull. At this price we have a sceraming BUY!

To: JOHN W. who wrote (3017)	11/27/1997 10:04:00 AM
From: Bhag Karamchandani	Read Replies (3) \| Respond to of 6136

Given the discussion on AGPH stock price, I would add the following for any one to check out the provocative hypothesis: Those who buy AGPH on good newslose money. Two examples: Typically for weeks before the two major press releases, from AGPH last year, first confirming Viracept's effectivenesss in a cocktail trial and the second announcing FDA approval, the stock price went up steadily prior to these announcements and then dropped sharply on the announcement. To a 'paranoid' this would suggest that there are some who are privy to 'highly reliable' rumours which allow them to take positions which get sold off on good news- when the average individual / retail customer usually buys in.